[1]
N. S. B. Rawson, “Alignment of health technology assessments and price negotiations for new drugs for rare disorders in Canada: Does it lead to improved patient access?”, J Popl Ther Clin Pharmacol, vol. 27, no. 1, pp. e48-e64, Feb. 2020, doi: 10.15586/jptcp.v27i1.658.